| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.05. | Charles River, Medipost Sign MOU to Advance GMP Testing Solutions | ||
| 12.05. | AOP Health, VRG Therapeutics Unite to Advance Inflammation and Immunology Target | ||
| 12.05. | Ribo, Insilico Medicine to Partner on AI-Driven siRNA Drug Development | ||
| 12.05. | Lonza Launches Xcite AAV Producer Cell Line Platform | ||
| 12.05. | Boehringer Ingelheim Advances Partnership with Brainomix to Improve Pulmonary Fibrosis Care | ||
| 12.05. | Quantitative Biosciences Institute Taps Dr. John Young as Chief Strategy Officer | ||
| 12.05. | BMS, Hengrui Pharma Partner to Advance Early Stage Programs | ||
| 12.05. | Aldevron, Minaris Renew Lentiviral Plasmid Agreement | ||
| 11.05. | Colbert Packaging Unveils New Vision Inspection Hardware and Software | ||
| 11.05. | Cellares, ProTgen to Automate Manufacturing of Novel Progenitor T-Cell Therapy | ||
| 11.05. | Avalere Health Launches Japan Office | ||
| 11.05. | Jean Luc Herbeaux Steps Down as CEO of Hovione | ||
| 11.05. | CPTx Adds Edward Rebar as CSO, Promotes David Maier to CBO | ||
| 11.05. | VIVEbiotech Adds EvoLVcell to Its Catalogue of LVV-Manufacturing Products | ||
| 11.05. | Charles River Laboratories Introduces AI-Powered, End-to-End Workflow | ||
| 11.05. | AGC Biologics Joins OXTL's Clinical Development Network as a Manufacturing Partner | ||
| 11.05. | Lilly to Invest an Additional $4.5B Across Two Indiana Sites | ||
| 08.05. | LenioBio and Twist Bioscience Partnering on AI Drug Discovery Models | ||
| 08.05. | Traws Pharma to Advance Potential Hantavirus Treatment Clinical Candidates | ||
| 08.05. | BMS Gets EU Approval for Sotyktu for Treatment of Active Psoriatic Arthritis | ||
| 08.05. | Harbour BioMed's IND for HBM7004 Cleared by FDA | ||
| 07.05. | Blackstone Life Sciences Invests $250M in Anagram Therapeutics for Pancreatic Enzyme Replacement Therapy | ||
| 07.05. | Carbogen Amcis Shanghai Site Successfully Completes Unannounced NMPA GMP Inspection | ||
| 07.05. | Adragos Pharma Appoints Konstantinos Rengis as CEO | ||
| 07.05. | Altasciences, Certara Partner to Accelerate Early-Phase Drug Development |